Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:9406319.
doi: 10.1155/2016/9406319. Epub 2016 Aug 24.

CEACAM1: Expression and Role in Melanocyte Transformation

Gabriela Turcu  1 , Roxana Ioana Nedelcu  2 , Daniela Adriana Ion  2 , Alice Brînzea  2 , Mirela Daniela Cioplea  3 , Lucia Beatrice Jilaveanu  4 , Sabina Andrada Zurac  3
Affiliations
Review

CEACAM1: Expression and Role in Melanocyte Transformation

Gabriela Turcu et al. Dis Markers. 2016.

Abstract

Metastases represent the main cause of death in melanoma patients. Despite the current optimized targeted therapy or immune checkpoint inhibitors the treatment of metastatic melanoma is unsatisfactory. Because of the poor prognosis of advanced melanoma there is an urgent need to identify new biomarkers to differentiate melanoma cells from normal melanocytes, to stratify patients according to their risk, and to identify subgroups of patients that require close follow-up or more aggressive therapy. Furthermore, melanoma progression has been associated with the dysregulation of cell adhesion molecules. We have reviewed the literature and have discussed the important role of the expression of the carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) in the development of melanoma. Thus, novel insights into CEACAM1 may lead to promising strategies in melanoma treatment, in monitoring melanoma patients, in assessing the response to immunotherapy, and in completing the standard immunohistochemical panel used in melanoma examination.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Zurac S., Neagu M., Constantin C., et al. Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors. Oncology Letters. 2016;11(5):3354–3360. doi: 10.3892/ol.2016.4391. - DOI - PMC - PubMed
    1. Kluger H. M., Hoyt K., Bacchiocchi A., et al. Plasma markers for identifying patients with metastatic melanoma. Clinical Cancer Research. 2011;17(8):2417–2425. doi: 10.1158/1078-0432.ccr-10-2402. - DOI - PMC - PubMed
    1. Markel G., Ortenberg R., Seidman R., et al. Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunology, Immunotherapy. 2010;59(2):215–230. doi: 10.1007/s00262-009-0740-5. - DOI - PubMed
    1. Sang M., Wang L., Ding C., et al. Melanoma-associated antigen genes—an update. Cancer Letters. 2011;302(2):85–90. doi: 10.1016/j.canlet.2010.10.021. - DOI - PubMed
    1. Lawrence M. S., Stojanov P., Polak P., et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214–218. doi: 10.1038/nature12213. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources